Clinical Trial: A Phase II Study to Evaluate the Efficacy and Safety of Pembrolizumab in Combination With Mitotane in Patients With Advanced Adrenocortical Carcinoma
Study Status: Completed
Recruit Status: RECRUITING
Condition: Adrenocortical Carcinoma
Study Type: INTERVENTIONAL
Official Title: A Phase II Study to Evaluate the Efficacy and Safety of Pembrolizumab in Combination With Mitotane in Patients With Advanced Adrenocortical Carcinoma
Brief Summary:
To learn if adding pembrolizumab to mitotane can help to control ACC.The safety of this drug combination will also be studied.
Read more